These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Fatal sepsis and systemic inflammatory response syndrome after off-label prasugrel: a case report. Serebruany VL, Kipshidze N, Pershukov IV, Kuliczkowski W, Carnes J, Atar D. Am J Ther; 2014; 21(6):e229-33. PubMed ID: 23665886 [Abstract] [Full Text] [Related]
26. [Cholestatic hepatitis as a ticlopidine-induced complication of treatment - a case report]. Kowalski R, Dropiński J, Brzostek T, Szot P, Rzeszutko M, Kasper M, Sawicka A, Szczeklik A. Kardiol Pol; 2008 Jul; 66(7):758-60. PubMed ID: 18690567 [Abstract] [Full Text] [Related]
28. [Cholestatic hepatitis and anemia induced by ticlopidine]. Pascual S, Sarrión JV, Jarque I, Argüello L, Berenguer J. Gastroenterol Hepatol; 1996 Apr; 19(4):208-9. PubMed ID: 8665360 [Abstract] [Full Text] [Related]
29. Thrombocytopenia and hepatitis complicating ticlopidine therapy. Friedman ND, Sitlington R, Lodge RS. Aust N Z J Med; 1997 Oct; 27(5):599. PubMed ID: 9404597 [No Abstract] [Full Text] [Related]
30. [Cholestatic hepatitis by ticlopidin]. García Ortega P, José Navarro J, Carvajal A, García del Pozo J. Med Clin (Barc); 2001 Jan 27; 116(3):117. PubMed ID: 11181293 [No Abstract] [Full Text] [Related]
31. Liver injury with the use of ticlopidine. Sossai P, Corte GD, Marenzi R. Ann Pharmacother; 1998 Dec 27; 32(12):1370-1. PubMed ID: 9876823 [No Abstract] [Full Text] [Related]
33. Ticlopidine-induced severe cholestatic hepatitis. Wu MS, Chan P, Lien GS, Cheng YS, Pan S. Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug 27; 63(8):663-6. PubMed ID: 10969455 [Abstract] [Full Text] [Related]
34. Bone marrow toxicity induced by clopidogrel. Maurício Adel C, Rosa MG, Cantadori L, Pereira CA, Gonçalves Rde S, Ruiz e Resende LS, de Melo LN, Matsubara BB, Bazan SG. Int J Cardiol; 2014 Jul 01; 174(3):e112-3. PubMed ID: 24820743 [No Abstract] [Full Text] [Related]
35. Ticlopidine-induced cholestatic hepatitis: report of three cases and review of the literature. Iqbal M, Goenka P, Young MF, Thomas E, Borthwick TR. Dig Dis Sci; 1998 Oct 01; 43(10):2223-6. PubMed ID: 9790457 [No Abstract] [Full Text] [Related]
36. Ticlopidine-induced cholestatic hepatitis with anti-nuclear antibody in serum. Tsai MH, Tsai SL, Chen TC, Liaw YF. J Formos Med Assoc; 2000 Nov 01; 99(11):866-9. PubMed ID: 11155780 [Abstract] [Full Text] [Related]
37. Clopidogrel and membranous nephropathy. Tholl U, Anlauf M, Helmchen U. Lancet; 1999 Oct 23; 354(9188):1443-4. PubMed ID: 10543675 [Abstract] [Full Text] [Related]
38. Clopidogrel-induced hypersensitivity syndrome associated with febrile pancytopenia. Comert A, Akgun S, Civelek A, Kavala M, Sarigül S, Yildirim T, Arsan S. Int J Dermatol; 2005 Oct 23; 44(10):882-4. PubMed ID: 16207199 [No Abstract] [Full Text] [Related]
39. Clopidogrel and ticlopidine cross-reactivity-induced erythroderma following drug-eluting stenting. Ziakas A, Theofilogiannakos EK, Daniilidis M, Sotiriadis D, Parisiadou A, Kotsaftis P, Gemitzis K, Parharidis G. Cutis; 2013 Dec 23; 92(6):E16-7. PubMed ID: 24416752 [No Abstract] [Full Text] [Related]